DealCollabConnecting People, Possibilities and Deals
Age (T)
30 days live
Forwards (F)
2 forwards
Advisors (D)
1 advisor
BUY-SIDE MANDATEACQUISITION OPPORTUNITY

Strategic Acquisition Interest in Diagnostics & Pathology Businesses

Strategic acquisition of South India diagnostic centres or pathology laboratories

Diagnostics & Pathology · South India

Illustrative Diagnostics & healthcare industry image. It represents the industry and does not depict the actual business.
Indicative transaction value
₹100 Cr

indicative

Annual revenue
₹20–75 Cr

historical

Business overview

The opportunity targets diagnostic centres and pathology laboratories operating in South India. These businesses provide a range of clinical testing and diagnostic services to patients and healthcare providers in the region.

The sector is characterized by fragmented ownership and growing demand for diagnostic services, making it attractive for consolidation and strategic expansion.

Products & services

  • diagnostic services
  • pathology laboratory services

Business highlights

Other highlights

  • Deal size of ₹100 Cr for a majority or 100% acquisition.
  • Target companies generate annual revenue between ₹20 Cr and ₹75 Cr.

Products & services

  • Focus on diagnostic centres and pathology laboratories in South India.

Transaction details

Type
Buy-side mandate
Structure
majority or 100% acquisition
Stake
majority or 100% acquisition
Objective
Strategic acquisition
Preference
Business owners, promoters, and intermediaries representing viable sell‑side opportunities operating in or around South India
Shared byJeevan Jadhav
Confidential|No company name disclosed|Powered by DealCollab
DealCollab